There was much news coverage of the announcement yesterday that Merck won’t try to get its cholesterol drug Tredaptive approved in the US after new questions about efficacy and safety were raised in a study. Bloomberg reported: Tredaptive was designed to raise levels of HDL, or “good” cholesterol. The findings call into question the benefits [...]
The Toronto Star reported, “New breast cancer drug heralded as breakthrough.” Let’s be clear about this at the outset: we’ve interviewed countless women with breast cancer and we share their yearning for breakthroughs. But we also share the healthy skepticism of many of the breast cancer survivors we’ve met about jumping to early conclusions about [...]
In a race for incomplete news coverage, news about a study in the journal Menopause, “Moderate alcohol intake lowers biochemical markers of bone turnover in postmenopausal women,” may outpace news from earlier in the week from a BMJ paper about alcohol and arthritis – both in volume and in missing key caveats. This was a [...]
This story focuses on a family that may have a rare genetic mutation that increases their risk of heart disease. Unfortunately, the “rare” part wasn’t mentioned until 1,600 words into this 2,100 word story.
While this story adequately addressed 7 of our 10 criteria, the 3 on which it missed were significant omissions, yet could have been easily addressed.
Solid medical conference reporting, with many expert interviews and good context provided. Goes far beyond the conference presentation itself.
We will not display your name or e-mail address on the site, nor will we share youre-mail address with any third parties.
For site updates and news from Gary, find us on Twitter:
HealthNewsReview: @HealthNewsRevu
Gary Schwitzer: @garyschwitzer
Copyright © 2013 Health News Review
